longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Innovative Eyewear

LUCY

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -1.05, within the reasonable range, cheaper than 64.71% of the time in the past 3 years, and the industry ranks 26/45, the industry Median -0.43.

-1.05xP/E
$0.94Stock price
$-0.89Earnings per share
-1.05xP/E
Stock price$0.94Earnings per share$-0.89

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-0.92x
Typical range
-1.27x–-0.74x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
017345168

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
BLCOUSBausch + Lomb
-36.18x94.03%$6.19B
MMEDUSMiniMed
-19.00x146.72%$5.96B
NEOGUSNeogen
-385.88x316.68%$3.05B
ESTAUSEstablishment Labs
-53.82x30.16%$2.09B
XRAYUSDentsply Sirona
-3.63x113.34%$1.98B
KIDSUSOrthopediatrics
-14.96x27.74%$594.26M
CERSUSCerus
-79.33x56.25%$538.07M
SMTIUSSanara Medtech
-10.13x104.59%$324.15M
OSURUSOraSure Tech
-5.60x29.79%$275.18M
RXSTUSRxSight
-4.37x0.58%$205.05M
SKYAUSSkyAI
-0.19x--$76.98M
TELAUSTela Bio
-1.54x17.67%$63.30M
ZTEKFUSZENTEK LTD
-8.07x--$60.53M
XTNTUSXtant Med
-4.46x477.77%$49.66M
RMTIUSRockwell Medical
-6.81x32.67%$35.69M
NSPRUSInspireMD
-0.67x--$35.28M
RVPUSRetractable Tech
-5.78x--$20.81M
CUPRUSCuprina
-3.87x--$13.94M
LUCYUSInnovative Eyewear
-1.05x--$8.08M
AIDXUS20/20 Biolabs
-0.84x44.74%$6.01M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.